Nutra Pharma Corp (NPHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,392 | -2,533 | -4,343 | -3,612 | -4,397 |
| Depreciation Amortization | 333 | 32 | 19 | 15 | 16 |
| Accounts receivable | 105 | -116 | 27 | -38 | 245 |
| Accounts payable and accrued liabilities | 28 | 559 | 430 | 169 | 738 |
| Other Working Capital | 595 | 432 | 526 | 291 | 1,257 |
| Other Operating Activity | 3,313 | 1,478 | 2,810 | 2,454 | 254 |
| Operating Cash Flow | $-1,018 | $-148 | $-531 | $-721 | $-1,888 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -22 | N/A | N/A | -1 |
| Investing Cash Flow | $-1 | $-22 | $N/A | $N/A | $-1 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 937 | 362 | 482 | 359 | 1,368 |
| Debt Repayment | -713 | -241 | -94 | -85 | -1,029 |
| Common Stock Issued | 786 | 60 | 140 | 447 | 1,551 |
| Other Financing Activity | 0 | 0 | 0 | 8 | 0 |
| Financing Cash Flow | $1,010 | $181 | $528 | $729 | $1,890 |
| Beginning Cash Position | 16 | 5 | 8 | N/A | N/A |
| End Cash Position | 7 | 16 | 5 | 8 | N/A |
| Net Cash Flow | $-9 | $11 | $-3 | $8 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,018 | -148 | -531 | -721 | -1,888 |
| Capital Expenditure | -1 | -22 | N/A | N/A | -1 |
| Free Cash Flow | -1,019 | -170 | -531 | -721 | -1,890 |